The estimated Net Worth of Terry M. Rich is at least $269 millier dollars as of 17 May 2018. Mr. Rich owns over 158,731 units of RTI Surgical stock worth over $182,421 and over the last 9 years he sold RTIX stock worth over $86,572. In addition, he makes $0 as President, Chief Executive Officer et Director at RTI Surgical.
Sign up
Mr. Rich RTIX stock SEC Form 4 insiders trading
Terry has made over 7 trades of the RTI Surgical stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 158,731 units of RTIX stock worth $498,415 on 17 May 2018.
The largest trade he's ever made was exercising 250,000 units of RTI Surgical stock on 12 October 2017 worth over $785,000. On average, Terry trades about 28,078 units every 48 days since 2015. As of 17 May 2018 he still owns at least 58,096 units of RTI Surgical stock.
You can see the complete history of Mr. Rich stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Terry Rich biography
Terry M. Rich serves as President, Chief Executive Officer, Director of the Company. Mr. Terry M. Rich joined the Company in November 2019. He previously served as President, Global Spine of the Company. Mr. Rich has over 25 years of experience in the orthopedic and spine industry. Prior to joining the Company, he led the turnaround of Alphatec Holdings, Inc. (“Alphatec”) from December 2016 through December 2018. Prior to Alphatec, from October 2015 to June 2016, Mr. Rich was the President, Upper Extremities, of Wright Medical Group, N.V., a global medical device company focused on extremities and biologics products. Prior to that, Mr. Rich served as Senior Vice President of U.S. Commercial Operations of Tornier, N.V., from March 2012 to October 2015, at which time Tornier and Wright Medical Group merged. Prior to joining Tornier, Mr. Rich held increasingly senior sales leadership positions at NuVasive, Inc., a San Diego-based spinal implant medical device company, from December 2005 until leaving the company in March 2012 as Senior Vice President, Sales, West.
How old is Terry Rich?
Terry Rich is 53, he's been the President, Chief Executive Officer et Director of RTI Surgical since 2020. There are 6 older and 4 younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.
What's Terry Rich's mailing address?
Terry's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, , DEERFIELD, IL, 60015.
Insiders trading at RTI Surgical
Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper et Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.
What does RTI Surgical do?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
What does RTI Surgical's logo look like?
Complete history of Mr. Rich stock trades at Alphatec Inc, RTI Surgical et Wright Medical NV
RTI Surgical executives and stock owners
RTI Surgical executives and other stock owners filed with the SEC include:
-
Jonathon Singer,
Chief Financial Officer, Chief Operating Officer -
John Varela,
Executive Vice President - Global Operations -
Olivier Visa,
Vice President - OEM, Sports and Donor Services -
Shirley Weis,
Independent Director -
Thomas McEachin,
Independent Director -
Mark Stolper,
Lead Independent Director -
Paul Thomas,
Independent Director -
Nicholas Valeriani,
Independent Director -
Pawel Lewicki,
Director -
Scott Durall,
Chief Commercial Officer -
Bryan Cornwall,
Executive Vice President - Research and Clinical Affairs -
Stuart Simpson,
Chairman of the Board -
Molly Poarch,
Director, Corporate Communications & Investor Relations -
Jeffrey Lightcap,
Independent Director -
Brian Kushner,
Director -
Ryan Bartolucci,
Vice President - Finance, Corporate Controller -
Terry Rich,
President, Chief Executive Officer, Director -
Lyle P. Luedeman,
-
Dean H Bergy,
Director -
Street Healthcare Partners ...,
-
Christopher R Sweeney,
Director -
Curtis M Selquist,
Director -
Peter F Gearen,
Director -
Brian K Hutchison,
Chairman, President and CEO -
Camille Farhat,
Chief Executive Officer -
Robert P Jordheim,
Executive Vice President/CFO -
Roger W Rose,
Vice President Donor Services -
Johannes Wynand Louw,
Vice President Finance -
Kevin D Brandt,
EVP CCO-Domestic Direct -
Joshua H De Rienzis,
General Counsel -
Philip R Chapman,
Director -
Ned Hoye Villers,
Director -
Adrian J R Smith,
Director -
Caroline A Hartill,
V.P. Quality Assurance -
Julianne M Bowler,
Director -
Roy D Crowninshield,
Director -
Gregory P Rainey,
Director -
Neal B Freeman,
Director -
Michael J La Prade,
Vice President -
Holdings Inc Zimmer,
10% owner -
Roderick N Allen,
Vice President -
David J Simpson,
Director -
Guy L Mayer,
President -
Michael J Odrich,
Director -
Lee Robert Jr Johnston,
Vice President -
Udo Henseler,
Director -
Christie J Blakely,
Vice President -
Robert J Lane,
Vice President -
Tara Leigh Zerby,
VP, Xenograft Technologies -
Carolyn Shaffer,
Vice President, Human Resource -
Thomas F Rose,
Vice President and CFO -
Michael T Manley,
Director -
Louis E Barnes,
Vice President-Cardiovascular -
Charles Randal Mills,
V.P. of Business Development -
William Melendez,
Vice President, Research & Dev -
Jeffrey Michael Schumm,
Vice Pres. and General Counsel -
Joseph W Condon,
Vice President-Operations